SOLID TUMORS
Clinical trials for SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new SOLID TUMORS trials appear
Sign up with your email to follow new studies for SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new type of immunotherapy called CAR T cells that are designed to recognize and attack cancer cells with a protein called CD70. It is for people with lymphoma, myeloma, sarcoma, or kidney cancer that has returned or not responded to standard treatme…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 29, 2026 01:37 UTC
-
Chill out cancer? new study combines cold therapy with immunotherapy
Disease control Not yet recruitingThis early-phase study tests whether spending time in a cool room (around 18°C) can make standard immunotherapy work better for people with solid tumors. About 24 participants will receive the cold exposure alongside their usual PD-1/PD-L1 inhibitor treatment. The main goals are …
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Apr 29, 2026 01:36 UTC
-
Engineered immune cells take aim at deadliest lung cancer
Disease control Not yet recruitingThis early-phase study tests a new treatment for people with extensive-stage small cell lung cancer or similar neuroendocrine cancers that did not respond to or came back after standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in a la…
Matched conditions: SOLID TUMORS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC